# Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus

> **NCT06701825** · PHASE4 · RECRUITING · sponsor: **Instituto de Investigación Hospital Universitario La Paz** · enrollment: 114 (estimated)

## Conditions studied

- Kidney Disease, Chronic
- Transplant Recipient (Kidney)
- Immunosuppression

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT06701825
- **Lead sponsor:** Instituto de Investigación Hospital Universitario La Paz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-02
- **Primary completion:** 2026-10-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2025-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06701825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06701825, "Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06701825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*